Ngā hua rapu - Markus Peck‐Radosavljevic

Whakamahine hua
  1. 1
    Review article: coagulation disorders in chronic liver disease

    Review article: coagulation disorders in chronic liver disease mā Markus Peck‐Radosavljevic

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Drug Therapy for Advanced-Stage Liver Cancer

    Drug Therapy for Advanced-Stage Liver Cancer mā Markus Peck‐Radosavljevic

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Thrombocytopenia in Liver Disease

    Thrombocytopenia in Liver Disease mā Markus Peck‐Radosavljevic

    I whakaputaina 1999
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Thrombocytopenia in chronic liver disease

    Thrombocytopenia in chronic liver disease mā Markus Peck‐Radosavljevic

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Review article: systemic treatment of hepatocellular carcinoma

    Review article: systemic treatment of hepatocellular carcinoma mā Matthias Pinter, Markus Peck‐Radosavljevic

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Transarterial chemoembolization: Modalities, indication, and patient selection

    Transarterial chemoembolization: Modalities, indication, and patient selection mā Wolfgang Sieghart, Florian Hucke, Markus Peck‐Radosavljevic

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups

    Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups mā Matthias Pinter, Bernhard Scheiner, Markus Peck‐Radosavljevic

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Oocytes from the Mutant Restricted Ovulator Hen Lack Receptor for Very Low Density Lipoprotein

    Oocytes from the Mutant Restricted Ovulator Hen Lack Receptor for Very Low Density Lipoprotein mā Johannes Nimpf, Markus Peck‐Radosavljevic, Wolfgang J. Schneider

    I whakaputaina 1989
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Cancer and liver cirrhosis: implications on prognosis and management

    Cancer and liver cirrhosis: implications on prognosis and management mā Matthias Pinter, Michael Trauner, Markus Peck‐Radosavljevic, Wolfgang Sieghart

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    The burden of liver disease in Europe: A review of available epidemiological data

    The burden of liver disease in Europe: A review of available epidemiological data mā Martin Blachier, Henri Leleu, Markus Peck‐Radosavljevic, Dominique Valla, Françoise Roudot‐Thoraval

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Systemic Therapy of Advanced Hepatocellular Carcinoma

    Systemic Therapy of Advanced Hepatocellular Carcinoma mā Peter R. Galle, Jean‐François Dufour, Markus Peck‐Radosavljevic, Jörg Trojan, Arndt Vogel

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma – a pilot study

    The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma – a pilot study mā Matthias Pinter, Wolfgang Sieghart, Thomas Reiberger, Nataliya Rohr‐Udilova, Arnulf Ferlitsch, Markus Peck‐Radosavljevic

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents

    Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents mā Bernhard Angermayr, Manfred Cejna, Franz Koenig, F. Karnel, Franz Hackl, Alfred Gangl, Markus Peck‐Radosavljevic

    I whakaputaina 2003
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Von Willebrand Factor as a new marker for non‐invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C

    Von Willebrand Factor as a new marker for non‐invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C mā A Maieron, Petra Salzl, Markus Peck‐Radosavljevic, Michael Trauner, S Hametner, R Schöfl, Péter Ferenci, Monika Ferlitsch

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Meta‐analysis: <scp>ARFI</scp> elastography versus transient elastography for the evaluation of liver fibrosis

    Meta‐analysis: <scp>ARFI</scp> elastography versus transient elastography for the evaluation of liver fibrosis mā Simona Bota, Harald Herkner, Ioan Sporea, Petra Salzl, Roxana Şirli, Adriana Maria Neghină, Markus Peck‐Radosavljevic

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Five‐year on‐treatment efficacy of lamivudine‐, tenofovir‐ and tenofovir + emtricitabine‐based HAART in HBV–HIV‐coinfected patients

    Five‐year on‐treatment efficacy of lamivudine‐, tenofovir‐ and tenofovir + emtricitabine‐based HAART in HBV–HIV‐coinfected patients mā Lana Kosi, Thomas Reiberger, B.A. Payer, Katharina Grabmeier‐Pfistershammer, Robert Straßl, Armin Rieger, Markus Peck‐Radosavljevic

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study

    Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study mā Rémy Schwarzer, Danijel Kivaranovic, Rafael Paternostro, Mattias Mandorfer, Thomas Reiberger, Michael Trauner, Markus Peck‐Radosavljevic, Arnulf Ferlitsch

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Rapid suppression of hematopoiesis by standard or pegylated interferon-α

    Rapid suppression of hematopoiesis by standard or pegylated interferon-α mā Markus Peck‐Radosavljevic, Martina Wichlas, Monika Homoncik–Kraml, Anna Kreil, Harald Hofer, Wolfgang Jessner, Alfred Gangl, Peter Ferenci

    I whakaputaina 2002
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    IP-10 Correlates with Hepatitis C Viral Load, Hepatic Inflammation and Fibrosis and Predicts Hepatitis C Virus Relapse or Non-Response in HIV–HCV Coinfection

    IP-10 Correlates with Hepatitis C Viral Load, Hepatic Inflammation and Fibrosis and Predicts Hepatitis C Virus Relapse or Non-Response in HIV–HCV Coinfection mā Thomas Reiberger, Judith H. Aberle, Michael Kundi, Norbert Kohrgruber, Armin Rieger, Alfred Gangl, Heidemarie Holzmann, Markus Peck‐Radosavljevic

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Personalized treatment of patients with very early hepatocellular carcinoma

    Personalized treatment of patients with very early hepatocellular carcinoma mā Alessandro Vitale, Markus Peck‐Radosavljevic, Edoardo G. Giannini, Éric Vibert, Wolfgang Sieghart, Sven Van Poucke, Timothy M. Pawlik

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: